Speaker illustration

Doctor Jie Wang

West China Hospital, Sichuan University, Chengdu (China)

Member of:

European Society of Cardiology

Jie WANG, M.D., Department of Cardiology, West China Hospital of Sichuan University. Dr. Wang specializes in the diagnosis and treatment of cardiomyopathies and the risk stratification by cardiac magnetic resonance imaging. Dr. Wang obtained the Ph.D. degree from the West China School of Medicine, Sichuan University and he has worked in the Centre for Computational Bioinformatics at the University of Birmingham, UK from 2019-2021 as a sponsored researcher. Dr. Wang has published more than 20 articles as the first or co-first author in the past five years, including cardiomyopathy-related publications in Radiology, JACC Cardiovasc Imaging, eClinicalMedicine, and other journals. Dr. Wang now also serves as the editorial member of the Journals of BMC cardiovascular disorders, etc.

Effect of obesity on myocardial tissue characteristics in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance-based study

Event: ESC Congress 2025

Topic: Myocardial Disease

Session: Cardiac magnetic resonance imaging insights into hypertrophic phenotypes

Thumbnail

Genetic architecture of hypertrophic cardiomyopathy in individuals of Chinese and UK

Event: ESC Congress 2025

Topic: Hypertrophic Cardiomyopathy

Session: Improved diagnosis of hypertrophic cardiomyopathy

Thumbnail

The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy

Event: ESC Congress 2024

Topic: T1 and T2 Mapping

Session: Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging

Thumbnail

The prognostic value of left ventricular entropy derived from native T1 mapping in patients with hypertrophic cardiomyopathy

Event: ESC Congress 2023

Topic: Myocardial Disease

Session: Risk stratification of sudden cardiac death in cardiomyopathies

Thumbnail